Hyogo, Japan

Masafumi Kinoshita

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: **Masafumi Kinoshita: A Pioneer in Human Serum Albumin Mutants**

Introduction

Masafumi Kinoshita is an innovative inventor based in Hyogo, Japan, recognized for his significant contributions to the field of biochemistry and pharmaceuticals. With four patents to his name, Kinoshita's work primarily focuses on enhancing the stability of physiologically active proteins in the blood through advanced bioengineering techniques. His research reflects a deep commitment to improving healthcare through innovative solutions.

Latest Patents

One of Kinoshita's latest patents involves a human serum albumin mutant designed to be linked with physiologically active proteins. This innovative mutant can significantly enhance the stability of such proteins within the bloodstream. The key aspect of the patent details a specific amino acid sequence, defined as SEQ ID NO:3, forming part of this mutant. Notably, this sequence allows for the preservation of critical residues while permitting minor variations. This type of engineering marks a substantial advancement in protein stability, crucial for therapeutic applications.

Career Highlights

Kinoshita has made substantial strides during his tenure at JCR Pharmaceuticals Co., Ltd., a notable company dedicated to innovative pharmaceutical solutions. His experience and knowledge have enabled him to carve a niche in the field of protein engineering, where his inventions have the potential to improve treatment protocols for various medical conditions. His commitment to research and development is evident through his substantial contributions to pioneering techniques in the industry.

Collaborations

Throughout his career, Kinoshita has worked alongside esteemed colleagues such as Hideto Morimoto and Kenichi Takahashi. These collaborations have allowed for a cross-pollination of ideas and techniques, fostering an environment ripe for innovation. Together, they contribute to the advancement of research and development initiatives, pushing the boundaries of what is possible in pharmaceuticals.

Conclusion

Masafumi Kinoshita stands out as a remarkable inventor whose work on human serum albumin mutants showcases the potential of biotechnological advancements in medicine. His dedication to innovation at JCR Pharmaceuticals Co., Ltd. not only demonstrates his expertise but also illustrates the crucial role inventors play in shaping the future of healthcare. As his patents reveal, Kinoshita continues to influence the medical field through innovative solutions that promise to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…